Fig. 5
From: Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer

Pathway crosstalk networks in 13 cancers.
From: Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer

Pathway crosstalk networks in 13 cancers.